NCT06542653 Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion
| NCT ID | NCT06542653 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital with Nanjing Medical University |
| Condition | Coronary Atheroscleroses |
| Study Type | OBSERVATIONAL |
| Enrollment | 258 participants |
| Start Date | 2023-09-17 |
| Primary Completion | 2024-09-17 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 258 participants in total. It began in 2023-09-17 with a primary completion date of 2024-09-17.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.
Eligibility Criteria
Inclusion Criteria: * patients with at least one coronary CTO lesion at our hospital in between January 2011 and December 2017 Exclusion Criteria: * (1) patients with ST-segment elevation myocardial infarction (STEMI) * (2)a history of coronary artery bypass grafting (CABG) * (3) cardiogenic shock * (4) malignant tumor. Patients were referred for PCI based on CTO-related symptoms or evidence of viability, or corresponding ischemia in the area of the CTO artery.
Contact & Investigator
Leilei Chen
STUDY DIRECTOR
The First Affiliated Hospital with Nanjing Medical University
Frequently Asked Questions
Who can join the NCT06542653 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Coronary Atheroscleroses. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06542653 currently recruiting?
Yes, NCT06542653 is actively recruiting participants. Contact the research team at 1513267113@qq.com for enrollment information.
Where is the NCT06542653 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT06542653 clinical trial?
NCT06542653 is sponsored by The First Affiliated Hospital with Nanjing Medical University. The principal investigator is Leilei Chen at The First Affiliated Hospital with Nanjing Medical University. The trial plans to enroll 258 participants.